Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001857417 | SCV002245723 | pathogenic | PRPH2-related disorder | 2024-01-17 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 305 of the PRPH2 protein (p.Gly305Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant retinal disease (PMID: 9338584; Invitae). ClinVar contains an entry for this variant (Variation ID: 98718). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Mendelics | RCV002247484 | SCV002519225 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Ophthalmic Genetics Group, |
RCV003324505 | SCV004030278 | likely pathogenic | Choroidal dystrophy, central areolar 2 | 2023-07-24 | criteria provided, single submitter | research | Clinical significance based on ACMG v2.0 |
Retina International | RCV000085031 | SCV000117167 | not provided | not provided | no assertion provided | not provided | ||
Leiden Open Variation Database | RCV000085031 | SCV001745123 | uncertain significance | not provided | 2021-04-06 | no assertion criteria provided | curation | Curator: Global Variome, with Curator vacancy. Submitter to LOVD: Manon Peeters. |